This 2012 photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test is planed to be discussed Wednesday, May 8, 2013 at an American Urological Association conference. (AP Photo/Myriad Genetics)

Associated Press
This 2012 photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test is planed to be discussed Wednesday, May 8, 2013 at an American Urological Association conference. (AP Photo/Myriad Genetics)
This 2012 photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. The new test is planed to be discussed Wednesday, May 8, 2013 at an American Urological Association conference. (AP Photo/Myriad Genetics)
View Comments